Skip to main content

Prostate and Urologic Cancers

Conducts and supports research on the prevention and early detection of prostate and bladder cancers. Develops and supports prevention trials and evaluation of new agents, surrogate biomarkers, and emerging technologies for identifying premalignant lesions.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	Asefa, Mela mela.asefa@nih.gov 240-276-6422	5E328	Program Support Assistant \| Breast and Gynecologic Cancer Program Support Assistant \| Prostate and Urologic Cancer
	House, Margaret, RN, B.S.N. margaret.house@nih.gov 240-276-7047	5E306	Deputy Chief \| Prostate and Urologic Cancer
	Parnes, Howard L., M.D. howard.parnes@nih.gov 240-276-7045	5E302	Chief \| Prostate and Urologic Cancer

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Salipante, Stephen J	University Of Washington United States	Efficient, cost-effective, and ultrasensitive sequencing of somatic mutations and methylation	1R33CA302385-01	Nicholas Hodges, Ph.D.
Salkowski, Lonie	University Of Wisconsin-Madison United States	Defining and Optimizing Critical Interpretation Skills in Screening Mammography to Improve Cancer Detection	5R37CA262110-04	Guillermo Marquez, Ph.D.
Salman, Emad	Florida Assn Of Pediatric Tumor Prog United States	The Florida Pediatric NCORP: NCI Community Oncology Research Program.	3UG1CA189973-11S1	Vanessa A. White, M.P.H.
Salvemini, Daniela	Saint Louis University United States	Fingolimod and Ozanimod for the treatment and prevention of chemobrain	5R01CA261979-04	Rachel Altshuler, Ph.D.
Sanchez, Eduardo Vilar	University Of Tx Md Anderson Can Ctr United States	Cancer Immune-Interception in a Spontaneous Non-Human Primate Model of Lynch Syndrome	5R01CA260761-04	Asad Umar, D.V.M., Ph.D.
Sanchez, Eduardo Vilar	University Of Tx Md Anderson Can Ctr United States	iCAN PREVENT: MD Anderson International Cancer Prevention Clinical Trials Consortium	2UG1CA242609-07	Donald Johnsey
Sanchez, Eduardo Vilar	University Of Tx Md Anderson Can Ctr United States	Cancer Immune-Interception for Lynch Syndrome	5R01CA257375-05	Asad Umar, D.V.M., Ph.D.
Sanda, Martin G	Emory University United States	Prostate Cancer Biomarker and Imaging Validation Alliance: Emory University, University of Alabama Birmingham, and University of Texas Southwestern	5U01CA113913-18	Indu Kohaar, Ph.D., M.Phil., M.Sc.
Sands, Stephen Alan	Sloan-Kettering Inst Can Research United States	Prospective international phase-III study to improve neurocognitive outcomes in young children with low-risk medulloblastoma (YCMB-LR)	5R01CA283045-02	Marjorie Perloff, M.D.
Santomasso, Bianca Denise	Sloan-Kettering Inst Can Research United States	Comprehensive Molecular and Clinical Characterization of Acute and Chronic Neurotoxicity Following CAR-T Cell Therapy	5R01CA293922-02	Monica Epstein, B.S.N., RN, OCN
Santos-Reyes, Luis Javier	Comprehensive Cancer Center/ Univ/Pr United States	Puerto Rico NCI Community Oncology Research Program (Puerto Rico NCORP)	3UG1CA189862-11S1	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Saphner, Thomas J	Aurora Health Care, Inc. United States	Aurora NCORP Community Site	3UG1CA190140-11S1	Vanessa A. White, M.P.H.
Schallenkamp, John M.	Montana Cancer Consortium United States	Montana Cancer Consortium: An Inclusive and Collaborative Approach to Clinical Trial Accrual and Cancer Care Delivery Research across Montana, Idaho and Wyoming	3UG1CA189872-11S1	Vanessa A. White, M.P.H.
Schaverien, Mark V	University Of Tx Md Anderson Can Ctr United States	Lymphedema Prevention Through Immediate Lymphatic Reconstruction	5R01CA292908-02	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Schedin, Pepper J	Oregon Health & Science University United States	NSAIDs During Postpartum Involution for Breast Cancer Chemoprevention	5R01CA169175-11	Brandy Heckman-Stoddard, Ph.D., M.P.H.